SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed three additional patent infringement suits relating to BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents. The first complaint was filed against Complete Genomics, Inc. and other BGI entities in the United States District Court for the Northern District of California alleging infringement of U.S. Patent Nos. […]
BEDFORD, Mass. — Cytonome/ST, LLC, a manufacturer of high throughput flow cytometry / sorting equipment, has filed a lawsuit in the United States District Court for the District of Delaware against NanoCellect Biomedical, Inc., a manufacturer of microfluidic solutions for bulk or single cell sorting. The lawsuit alleges unauthorized use of Cytonome/ST’s patent technology, which is prohibited by law, and is […]
Illumina’s proposed takeover of PacBio raises competition concerns in the supply of specialist DNA sequencing systems in the UK, a CMA investigation has found. The Competition and Markets Authority (CMA) has been investigating the proposed $1.2 billion merger of Illumina, Inc. (Illumina) and Pacific Biosciences of California, Inc (PacBio). The companies are both global suppliers […]
WILMINGTON, Delaware, USA — DeNovix Inc. announces the award of US Patent 10,302,568 for their innovation in the field of cell counting. The CellDrop Automated Cell Counter, engineered with DirectPipette™ Technology, is the first image-based cell counter that completely eliminates the need for slides. The CellDrop Series features permanent sample surfaces that form a reusable […]
Existing Supply Agreement Remains Intact WALTHAM, Mass. and SARASOTA, Fla. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Roper Technologies (NYSE: ROP), a leading diversified technology company, today announced that they have mutually terminated the agreement under which Thermo Fisher would have acquired Gatan, Inc., a wholly owned subsidiary […]
USPTO issues sixth CRISPR-Cas9-related patent to University of California for genome editing and modulation of gene expression BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent (U.S. Patent No. 10,308,961) to University of California (UC) covering additional methods of using the CRISPR-Cas9 system. The unique methods form a toolset for both editing genes and […]
SAN JOSE, Calif. — Complete Genomics Inc., a US subsidiary of MGI, has filed a patent infringement lawsuit against Illumina in US District Court for the District of Delaware. The lawsuit alleges that a number of genetic sequencers and related reagents from Illumina, including the NovaSeq 6000, NextSeq series, and MiniSeq, are infringing Complete Genomics’ U.S. Patent No. 9,222,132 […]
USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable […]
USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable […]
SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed another patent infringement suit against one of BGI Group’s subsidiaries, BGI Europe A/S. Illumina filed suit in the Maritime & Commercial High Court of Denmark. “As we have previously stated, Illumina will continue to vigorously protect our patented technology and file patent suits where appropriate when our […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
